metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Invasive pneumococcal disease in a tertiary hospital in Madrid: are we using pne...
Journal Information
Share
Share
Download PDF
More article options
Visits
90
Brief report
Available online 4 October 2024
Invasive pneumococcal disease in a tertiary hospital in Madrid: are we using pneumococcal vaccine correctly?
Enfermedad neumocócica invasiva en un hospital terciario de Madrid: ¿estamos utilizando correctamente la vacuna antineumocócica?
Visits
90
María Isabel Serrano-Tomása, Margarita Cabelloa, Paloma Moreno-Nuñezb, Juan Carlos Sanzc,d, Rafael Cantóna,e, Ana María Sánchez-Díaza,
Corresponding author
anamsd.micro@gmail.com

Corresponding author.
a Servicio de Microbiología Clínica, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
b Servicio de Medicina Preventiva, Hospital Universitario Ramón y Cajal, Madrid, Spain
c Unidad de Microbiología Clínica, Laboratorio Regional de Salud Pública de la Comunidad de Madrid, Dirección General de Salud Pública, Madrid, Spain
d Consorcio de Investigación Biomédica de Epidemiología y Salud Pública (CIBERESP), Spain
e CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (1)
Table 1. Characteristics of patients and S. pneumoniae isolates.
Abstract
Introduction

Invasive pneumococcal disease (IPD) is of concern. We describe the epidemiology and assess the vaccination schedule adequacy of IPD episodes (2019–2021) in northern Madrid.

Methods

Clinical, laboratory and vaccination data were collected from clinical/epidemiological records. Antimicrobial susceptibility testing was performed according to EUCAST and serotyping by Pneumotest-agglutination/Quellung.

Results

IPD was identified in 103 patients (71 [IQR 23.5] year-old; 50.4% males), 85.4% associated with bacteremia and a high mortality rate (19.4%). Serotypes 8 (29.9%), 3 and 22F (8% each) were dominant (45.9%), all antibiotic-susceptible. β-Lactams increased MICs and macrolide resistance were mainly linked to serotypes 19A, 23F, 24F, 6C, and 15A. Only 10.5% of adults eligible for vaccination had an adequate vaccine regimen before IPD being 40% due to nonvaccine-preventable serotypes (13, 23B, 24F, 31).

Conclusion

IPD episodes were dominated by antibiotic-susceptible ST8 and frequently occurred in adults at risk. Despite recommendations, vaccination adherence rates were very low.

Keywords:
Invasive pneumococcal disease
Adult vaccination
PCV13
PPSV23
Serotypes
Resumen
Introducción

Describimos la epidemiología y evaluamos la adecuación de la vacunación de los episodios de la enfermedad neumocócica invasiva (ENI) (2019-2021) en el norte de Madrid.

Métodos

Los datos se obtuvieron de registros clínicos/epidemiológicos, las pruebas de sensibilidad se realizaron mediante criterios EUCAST y el serotipado mediante Pneumotest/Quellung.

Resultados

Se detectaron 103 casos en varones (50,4%) asociados a bacteriemia (85,4%) con una elevada tasa de mortalidad (19,4%). Predominaron (45,9%) los serotipos sensibles a antibióticos: 8, 3 y 22F. El aumento de CMI para β-lactámicos/resistencia a macrólidos se detectó en los serotipos 19A, 23F, 24F, 6C y 15A. Solo el 10,5% de los adultos candidatos a vacunación tenían una adecuada pauta vacunal antes del episodio y el 40% se debió a serotipos no prevenibles mediante vacunación.

Conclusiones

Los episodios de ENI ocurrieron frecuentemente en adultos de riesgo y se debieron al serotipo 8. Pese a las recomendaciones, las tasas de adherencia a la vacunación fueron muy bajas.

Palabras clave:
Enfermedad neumocócica invasora
Vacunación de adultos
PCV13
PPSV23
Serotipos

Article

These are the options to access the full texts of the publication Enfermedades Infecciosas y Microbiología Clínica
Member

Socio de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica

Para acceder a la revista

Es necesario que lo haga desde la zona privada de la web de la SEIMC, clique aquí

Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Enfermedades Infecciosas y Microbiología Clínica

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos